Recently, IPNB has been reported to share mutational profiles with extrahepatic CCA, including mutations in TP53, SMAD4, and KRAS and deletions on chromosomes 9q, 17p, and 18q. This evidence concerns the gene KRAS and cholangiocarcinoma.